About Autolus Therapeutics
Autolus is a London-based clinical-stage biopharma developing next-generation programmed T-cell (CAR-T) therapies for cancer.
Sector
Biotech
Headquarters
London, United Kingdom
Founded
2014
Employees
700
In the News
AUTO-PULLEDNo coverage yet — our newsroom tracks Autolus Therapeutics continuously.